高级检索
当前位置: 首页 > 详情页

Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Ji Xing Pharmaceuticals (Shanghai) Co., Ltd. [2]LENZ Therapeutics, Inc [3]Eye Hospital, Wenzhou Medical University,Wenzhou,Zhejiang,China [4]Beijing Tongren Hospital, Capital Medical University,Beijing,China [5]Peking University First Hospital,Beijing,China [6]The Second Xiangya Hospital of Central South University,Changsha,China [7]Ineye Hospital of Chengdu University of TCM,Chengdu,China [8]Guang Zhou Aier eye Hospital,Guangzhou,China [9]Zhongshan Ophthalmic Center, Sun Yat-sen University,Guangzhou,China [10]The Affiliated Hospital of Guizhou Medical University,Guizhou,China [11]Henan Eye Hospital & Henan Institute,Henan,China [12]The affiliated Hospital of Inner Mongolia Medical University,Hohhot,China [13]Affiliated Eye Hospital, Shandong University of Traditional Chinese Medicine,Shandong,China [14]Shanghai Eye Disease Prevention and Treatment Center,Shanghai,China [15]Tongji Hospital Of Tongji University,Shanghai,China [16]Xinhua Hospital Affiliated to Shanghai Jiao Tong University School Of Medicine,Shanghai,China [17]Shanxi Eye Hospital,Shanxi,China [18]West China Hospital, Sichuan University,Sichuan,China [19]Tianjin Eye Hospital,Tianjin,China [20]Tianjin Medical University Eye Hospital,Tianjin,China [21]Wuhan Aier Eye Hospital,Wuhan,China [22]Xi'An People's Hospital,Xi'an,China

关键词: Presbyopia Pharmaceutical Solutions Opthalmic Solutions Eye Drops Miotic

研究目的:
Phase 3 Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Treatment of Presbyopia

资源点击量:21166 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)